For the therapeutic drug development, targeted photodynamic therapy (tPDT) using the anti-FAP antibody 28H1 coupled to the photosensitizer IRDye700DX moderately delayed the collagen-induced arthritis development in mice [42]. This evidence concerns the gene FAP and Arthritis.